SCHE Offers Higher Yield and Lower Fees Than NZAC

SCHE offers lower fees at 0.07% and a higher dividend yield of 2.7% versus NZAC’s 0.12% expense ratio and 1.8% yield. NZAC adds a climate-focused ESG screen and broader global exposure, but its portfolio is heavily tilted to technology at 30% and includes 672 stocks versus SCHE’s 2,200+ holdings. The article is comparative and informational, with limited immediate price impact.

Analysis

The key second-order issue is not just fee or yield differential, but portfolio concentration of factor exposure. SCHE is a cleaner EM beta vehicle: it gives you more direct participation in cyclically levered Asian manufacturing and commodity-linked growth, while NZAC is effectively an ESG-filtered global growth proxy with a heavy U.S. mega-cap tech backbone. That means the “global diversification” label on NZAC understates its sensitivity to duration, AI capex enthusiasm, and U.S. large-cap multiple expansion.

This setup creates a hidden winner/loser dynamic across underlying holdings. NZAC’s top weights benefit from any easing in long-end yields and continued AI infrastructure spending, but the climate screen likely excludes or underweights more carbon-intensive cash-generators, reducing ballast in a risk-off tape. SCHE, by contrast, is more exposed to China/Taiwan policy headlines and EM earnings revisions, but its higher dividend yield and lower fee make it better suited for capital allocation in a range-bound market where investors are paid to wait.

Catalyst-wise, the next 1-3 months should be driven less by headline ESG debate and more by rates and the U.S. dollar. If real yields back up, NZAC’s tech tilt is the more vulnerable construct; if the dollar weakens or China policy improves, SCHE should outperform because its revenue base is more directly tied to EM operating leverage. The main contrarian point is that NZAC may be less “green premium” and more “growth basket with a climate label,” so investors paying up for ESG could be unintentionally doubling down on the same mega-cap names they already own elsewhere.

The cleanest trade is relative value rather than outright beta: long SCHE / short NZAC into any episode of rising yields or narrowing AI leadership, with a 2-4 month horizon and a stop if U.S. tech breadth re-accelerates. For investors already long U.S. mega-cap growth, NZAC is the less differentiated sleeve and can be trimmed in favor of SCHE for lower fee drag and higher cash yield. The risk to this view is a sharp EM risk-off event, especially from China or Taiwan, which would hit SCHE harder than NZAC over days to weeks.

Key Decisions for Investors

• Go long SCHE / short NZAC as a 2-4 month relative-value pair; thesis is that higher real yields and tech crowding hurt NZAC more than EM beta hurts SCHE. Target 5-8% spread capture; stop if U.S. tech leadership broadens materially.
• If already overweight U.S. mega-cap growth, fund the position by trimming NZAC first; it is the least differentiated way to own NVDA/AAPL/MSFT-like exposure with an ESG wrapper.
• Buy SCHE on pullbacks as a carry-plus EM recovery vehicle; the 2.7% yield and 0.07% fee make it superior for a 6-12 month hold if the dollar softens.
• Avoid using NZAC as a pure climate hedge; treat it as a tech-heavy global growth proxy and size accordingly, especially if rates are trending higher over the next quarter.
• For more convexity, consider call spreads on SCHE rather than outright equity if you expect a China/Taiwan policy bounce but want defined downside over the next 1-3 months.